The Cultivated B has developed a synthetic molecule, TCB-32, which can replace basic fibroblast growth factor (bFGF) in cell culture for cultivated meat production. TCB-32 is stable for at least 13 days, reducing the need for frequent replenishment and cutting costs. Its chemical synthesis allows for consistent quality and scalability, addressing a major bottleneck in cultivated meat production and making it a more affordable and competitive option compared to conventional meat.

This innovation could have a significant impact on industries relying on cell cultures, including biopharmaceuticals. By offering a stable and cost-effective growth factor alternative, The Cultivated B is unlocking new possibilities for biotechnological applications. The company has shared its research findings with the scientific community and is positioning itself at the forefront of biomanufacturing innovation with the potential to revolutionize cell-based product manufacturing.